Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW – Medical Marijuana Initiative Cleared for 2020 Mississippi Vote

A medical marijuana legalization question will be on the 2020 ballot, allowing the residents of Mississippi to decide on the legalization of medical cannabis. If the voters approve ballot initiative 65, it will amend the state’s constitution so that people with debilitating health conditions, which are included in the list of qualifying conditions such as cancer and epilepsy, would be able to access medical marijuana.

In July 2018, the Medical Marijuana 2020 campaign sponsored by the Mississippians for Compassionate Care political group, kick-started the petition for the constitutional amendment. This was after the draft ballot initiative was approved by the Mississippi Secretary of State and the Mississippi Attorney General’s office.

On September 4, the completed petitions were submitted, and a little over four months later, the Secretary of State’s office in Mississippi confirmed that the petition had enough signatures qualifying it for placement on the ballot.

Each of the five Congressional districts had to generate around 17,237 signatures making it a total of 86,185. The Mississippians for Compassionate care turned in more than 105,000 signatures that were verified.

In an interview with The Daily Mississippian, the Medical Marijuana 2020 communications director, Jamie Grantham, said that when they were drafting the language for the medical marijuana initiative, they looked at other states, studied their programs, people, and patients who benefited from those programs.

The proposed medical marijuana amendment provides that patients are not supposed to carry more than 2.5 ounces of medical marijuana at any one time and that patients should not be sold more than the 2.5 ounces in a span of 14 days. It also provides that medical marijuana treatment centers should be more than 500 feet away from schools, churches, or childcare institutions.

The legislature in the state of Mississippi has about four months to review, change, adopt or reject the measure before the November 3 elections. According to Section 23-17-29 of the Mississippi Code Annotated, if they opt to amend, both the original and amended versions of the measure will be on the ballot. The code also stipulates that the medical marijuana initiative must have 40% of the total votes cast if it is to be implemented.

In an interview with The Daily Mississippian, the Director of Pharmacy Health Services, Sandy Bentley, said that every medication has some risk. She further noted that doctors prescribe the drug because the benefits overshadow the dangers and that medical marijuana is no different.

Bentley further said that medical marijuana should be judged on a case-by-case basis. She also said that she does not think that medical marijuana can have a blanket policy.

The initiative is being vehemently opposed by the Mississippi Board of Health, citing that several known harms are resulting from the use of marijuana products. These harms include addiction, mental illness, increased accidents, and smoking-related illnesses.

That opposition notwithstanding, experts believe that cannabis companies like No Borders Inc. (OTC: NBDR) are hopeful that voters will support the initiate that seeks to give them an additional treatment option in case they are faced with a health challenge.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CBDNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Technology Accelerates Delivery of CBD into Bloodstream

Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) 2.0 version of its patented DehydraTECH(TM) oral drug-delivery technology has demonstrated its power to deliver more cannabidiol (“CBD”) into the bloodstream than generic industry-control formulations (http://cnw.fm/4wHA6). An article discussing the company reads, “The company’s 2.0 technology is specifically being developed for effectiveness in helping to deliver its drug payload across the blood-brain barrier, a natural biological system of blood vessels and endothelial cells that bar most drugs from accessing the brain’s central-nervous-system hierarchy. The ability to effectively deliver drugs to the brain is of keen interest to developers of drugs designed to beneficially target the central nervous system. . . . Lexaria’s research and development showed that DehydraTECH version 2.0 was able to deliver 1,937% more CBD into brain tissue than generic industry-control formulations and 487% more than the original DehydraTECH technology, according to the company’s news release.”

To view the full article, visit http://cnw.fm/h7lGM

About Lexaria Bioscience Corp.

Lexaria Bioscience is a global innovator in drug-delivery platforms. The company’s patented DehydraTECH drug-delivery technology changes the way active pharmaceutical ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bioabsorption, reduces time of onset and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (“NSAIDs”), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products, as well as to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed, in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXRP

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) Advancing CBD Initiatives

ChineseInvestors.com (OTCQB: CIIX), a leading financial information website for Chinese-speaking investors in the United States and China, is capitalizing on the rising demand for cannabidiol (“CBD”)-based nutrition and health products. A recent article discussing the company reads, “CIIX’s CBD initiatives are carried out by its subsidiary, CBD Biotech Inc. In essence, CIIX is taking advantage of its own financial expertise to establish itself as a leader in China’s developing CBD industry. Through CBD Biotech, CIIX has established a three-year development plan to capitalize on the union of CBD and the nutrition and health-products market in mainland China. . . . Subsequent to entering into a wholesale agreement with a well-known CBD health brand in December 2016, CIIX formally launched the website ChineseCBDOil.com (http://cnw.fm/TpvQ6). This website is one of the world’s first online stores in the Chinese language, providing industrial-hemp-derived CBD products for Chinese-speaking customers around the world. Products available on the site include soft gels, capsules and concentrates. In addition, CIIX opened a retail store in San Gabriel, California, which has a high Chinese population.”

To view the full article, visit http://cnw.fm/6maYF

About ChineseInvestors.com Inc.

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company by providing (a) real-time market commentary, analysis and educationally related services in both traditional and simplified Chinese language character sets; (b) advertising and public-relations-related support services; and (c) retail, online and direct sales of hemp-based products and other health-related products. For more information, visit the company’s website at www.ChineseInvestors.com.

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX

About CBDWire

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Sugarmade, Inc. (SGMD) Announces New, Bold Shift in Business Strategy, Eyes On-Demand Revolution of the Cannabis Sector

Sugarmade (OTCQB: SGMD) today announced a new and bold shift in its business strategy toward the virtualization of the cannabis sector as part of the major shift in the U.S. business model toward an on-demand economy. According to the update, Sugarmade will make several strategic moves over the coming weeks as it launches on-demand and related business operations via internally developed initiatives and new relationships with proven sector business operators. “Things are changing in society and in the economy as virtualization proliferates. Many of the most dynamic and innovative growth companies are part of this on-demand revolution and it is our goal to ensure Sugarmade is an important component of these trends. We see the acceleration of on-demand services within the cannabis sector and we believe it is the most lucrative area for us to pursue,” Sugarmade CEO Jimmy Chan said in the news release. “We have radically changed our business model via internally developed initiatives and through upcoming relationships with established sector participants. Our investors should stay tuned for our new business model to develop over the coming weeks.”

To view the full press release, visit http://cnw.fm/xs1U2

About Sugarmade, Inc.

Sugarmade, Inc. (OTCQB: SGMD) is a product and branding marketing company investing in operations and technologies with disruptive potential. For more information, visit the company’s website at www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SUGAR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

HempNewsBreaks – HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) Closes Deal to Purchase Hemp Extraction Company Kase Farma Inc.

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF), a hemp-biomass processing entity, this morning announced the closing of its previously announced share and purchase agreement (“SPA”) with Starling Brands, Inc., a party at arm’s length to HTC, pursuant to which HTC purchased all the issued and outstanding shares of Kase Farma Inc. Kase Farma, which is authorized to operate in the areas of hemp cultivation, extraction, refining and formulation in the State of California, is now a wholly owned subsidiary of HTC. In accordance with the agreement, the company retains the management services of Starling, led by highly regarded experts in the cannabinoid extraction, formulation and refining industry, CEO Mike Reynolds and chief science officer Drew Ford. “On behalf of Starling, we are extremely excited to integrate our experience, know-how and pedigree with HTC’s technologies and pedigree, to further the vision and execution as global leaders in the science and production of the highest quality cannabinoid extractions and formulations. The benefits of our products will be provided to the global community consistent with the irreversible momentum of changing perceptions and acceptance of the planet’s most useful and beneficial plant,” Starling Brands CEO Mike Reynolds stated in the news release.

As part of the transaction, Kase Farma has entered into an intellectual property licensing agreement with Starling. This agreement allows for a technology transfer in which intellectual property and technology licensed under this agreement will be used and deployed in HTC’s Canadian facility. Total consideration payable to Starling pursuant to the Transaction is US$900,000 in cash and the issuance of 8,000,000 units of HTC and 2,000,000 bonus units of HTC. Each unit is comprised of one common share and one half of one common share purchase warrant. Each warrant will be exercisable to acquire one common share at a price of C$0.70 for a period of 36 months from the completion of the transaction. Each bonus unit is comprised of one common share and one half of one common share bonus purchase warrant of HTC. Each bonus warrant shall be exercisable to acquire one common share at a price of C$1.00 for a period of 36 months from the completion of the transaction. The units and bonus units (collectively, the “compensation units”) are subject to legends restricting their transfer and which will provide that: (i) one-third of the compensation units shall become freely tradeable 12 months after the completion of the transaction; (ii) one-third of the compensation units shall become freely tradeable 18 months after the completion of the transaction; and (iii) one-third of the compensation units shall become freely tradeable 24 months after the completion of the transaction. In addition, HTC will be paying compensation to Hillcrest Merchant Partners Inc., an arm’s length party, in the form of units, for the development, negotiation and finalization of the ancillary agreements to the SPA. All common shares issued pursuant to the transaction and as compensation, are subject to a hold period under applicable securities law until May 29, 2020.

To view the full press release, visit http://cnw.fm/O5L5b

About HTC Extraction Systems

HTC Extraction Systems has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp-biomass and cannabidiol (“CBD”) industry as well as gas and liquid extraction. HTC’s extraction and purification systems are engineered to large scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced. For more information, visit the company’s website at www.HTCExtraction.com.

NOTE TO INVESTORS: The latest news and updates relating to HTC are available in the company’s newsroom at http://cnw.fm/HTC

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

420 with CNW – Chicago Passenger Caught Stealing from Marijuana Amnesty Box

Last week on Wednesday, an incoming traveler at Midway Airport stole marijuana from one of the marijuana amnesty boxes situated at the facility, said the Chicago Police.

The cannabis amnesty boxes were installed a few weeks ago, and they coincided with adult-use marijuana legalization in Illinois. The amnesty boxes are for passengers who are boarding their flights at Midway or O’Hare airports to dispose of the unused marijuana products since no one is allowed to board a plane with any shred of weed.

According to local media sources, during routine checks on Wednesday evening around 8 p.m., the police noticed that marijuana was missing from one of the amnesty boxes. When they checked the surveillance footage near the location of the box, the police saw a man reach inside and remove the weed several hours before. The police believe that the man was an incoming passenger.

During an earlier security check, one of the passengers was found with the weed and was forced to leave it behind, thus placing it in the amnesty box. It is this weed that another passenger stole. As of last Friday, they had not identified the man, but authorities say that it shouldn’t be possible for someone to access the contents of the amnesty boxes.

The chief of communications with the Chicago police, Anthony Guglielmi, said that the marijuana amnesty boxes were placed at the airports in Chicago to make sure that travelers complied with the federal and local state laws of their destinations. Guglielmi also noted that in the coming weeks, they would replace the temporary amnesty boxes with other boxes to prevent theft, making them secure and hinder anyone from looting their contents.

The Department of Aviation in Chicago and the Chicago police were tasked with overseeing, emptying, and discarding the content found inside the 12 boxes.

The TSA clarified that it is legal to have marijuana at the airports, but it is unlawful to fly with drugs since the federal authorities regulate the airspace, and marijuana is federally illegal.

Speaking to local media at the beginning of the month, the TSA spokesperson said that the agency does not search for marijuana-infused products during security checks across the U.S., but TSA agents are under obligation to report if they discover any drugs or substances that are illegal as per the federal law. After the report is made, local police determine the next course of action.

Other airports that have installed amnesty boxes include McCarran International Airport in Las Vegas and Colorado Springs Airport in Colorado.

Analysts believe that marijuana companies like Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) may be shocked that the amnesty boxes were not designed to prevent unauthorized access, such as what happened at the Chicago airport.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Mexican Lawmakers Get Set to Legalize Pot in April

As the legislature resumes their sessions next month in Mexico, lawmakers are preparing to push for marijuana reform since they have been seen circulating an amended bill amongst themselves. The amended legislation seeks to legalize and regulate cannabis sales within Mexico.

The amended legislation was filed by the Justice and Health committees. It would allow possession of a maximum of 28 grams of marijuana per adult and cultivation of a maximum of six plants for personal use. It also has a provision allowing people to apply for a license to carry more than 28 grams of weed but not above 200 grams.

Next week Senator Ricardo Monreal Avial will be holding a meeting with the Interior Secretary Olga Sanchez Cordero and the legal advisor to the president, Julio Scherer, to discuss the marijuana reform bill since the proposed measure is not final, and he considers it as a next step process.

The amended legislation has a provision where people found carrying marijuana ranging from 28 grams to 200 grams would be charged a fine of about $560. Stringent measures would be taken against adults found possessing more than 200 grams of weed.

A new regulatory body, the Mexican Cannabis Institute, would be created to issue business licenses and create rules for the marijuana market. The legislation also aims to promote social equity by prioritizing people from areas impacted by prohibition when issuing cultivation permits.

According to Milenio, the Mexican Marijuana Institute would also be allowed to fund research on the cultivation of marijuana, which is to be sold commercially through grants.

The amended bill comes a year plus after the Supreme Court in Mexico passed a ruling to end federal laws prohibiting cultivation and possession of marijuana deeming it unconstitutional. Since then, lawmakers have been working to establish a scheme allowing recreational marijuana in the country.

The Senate made progress with the bill by holding several public gatherings to educate the public, and in one of the meetings, they featured a former White House drug czar, but the legislature did not meet the court-appointed deadline for the approval of the legislation, which was October 2019; therefore, they requested for an extension. The Supreme Court extended the deadline to April 30, 2020.

The new bill has some minor changes, such as amending the business licensing scheme where it classifies it into five types of licenses. These include cultivation, transformation/processing, marketing, exports, and imports as well as research.

Montreal said that some leaders are not in favor of the measure, but the lawmakers are hoping to legalize marijuana before the deadline.

It would be interesting to hear what cannabis companies like Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) have to say about the implications of legalizing recreational marijuana in Mexico.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) Announces Changes to Executive Leadership Team

Global cannabis company TerrAscend (CSE: TER) (OTCQX: TRSSF) this morning announced that it has made modifications to its leadership team in coordination with the company’s focus on its rapidly scaling U.S. retail, manufacturing, and distribution operations. Michael Nashat has stepped down as CEO but will continue to serve as a member of the Board of Directors and act as a strategic advisor to the company. Jason Ackerman, executive chairman of the company, has been named interim CEO. “While it was a difficult decision, I believe given TerrAscend’s premier operating assets in the United States, it is now time for me to step into an advisory role and let new U.S.-based management guide TerrAscend as they expand and scale,” Michael Nashat stated in the news release. “Jason’s experience in omnichannel retail, distribution and operations are skills that TerrAscend will lean on as it enters this new growth phase. In my time working alongside Jason, it is clear that he is the right person to take on this role, and as a large shareholder, I believe this is what is best for securing TerrAscend’s future. I look forward to continuing to advise the company in my board position and as a strategic advisor.”

To view the full press release, visit http://cnw.fm/JWtG1

About TerrAscend

TerrAscend provides quality products, brands, and services to the global cannabinoid market. As the first North American Operator (“NAO”), with scale operations in both Canada and the US, the company participates in the medical and legal adult use market across Canada and in several US states where cannabis has been legalized for therapeutic or adult use. TerrAscend is the first and only cannabis company with sales in the US, Canada, and Europe. TerrAscend operates a number of synergistic businesses, including The Apothecarium, an award-winning cannabis dispensary with several retail locations in California; Arise Bioscience Inc., a manufacturer and distributor of hemp-derived products; Ilera Healthcare, Pennsylvania’s premier medical marijuana cultivator, processor and dispenser; Ascendant Laboratories Inc., a biotechnology and licensing company committed to the continuous improvement of cannabinoid expressing plants; Solace RX Inc., a proposed Drug Preparation Premises (“DPP”) focused on the development of novel formulations and delivery forms; and Valhalla Confections, a manufacturer of premium cannabis-infused edibles. Additionally, TerrAscend holds a cultivation permit in the State of New Jersey and is pending approval for a vertically integrated medical cannabis operation with the ability to operate up to three alternative treatment centers. For more information, visit the company’s website at www.TerrAscend.com.

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Missouri Licenses 192 Medical Cannabis Dispensaries

One hundred and ninety-two dispensaries were issued with permits by the state of Missouri, allowing them to sell medical marijuana to patients. Of the 192 dispensaries, eight are located in Springfield City.

Missouri has eight Congressional districts, and each of them was issued with 24 licenses by the state Department of Health and Senior Services. The department indicated that the recipients of the permits met the requirements of the program and that they scored the highest during the evaluation of the license applicants. There were more than 1,200 applications for dispensary licenses within the state.

Medical marijuana was legalized in Missouri in 2018, but since cannabis must be grown at farms that have been tested and approved in the state, marijuana sales are expected to start this summer.

The Kansas City Star reported that as of Tuesday of last week, the health department had approved medical marijuana identification cards to 29,457 patients, and 820 caregivers.

The patients are allowed to apply for medical marijuana cards once they receive certification from their physician. The list of qualifying conditions includes cancer, epilepsy, glaucoma, migraines, chronic pain, HIV or AIDS, debilitating psychiatric disorders, and any other terminal illness.

In December last year, the Department of Health and Senior Services in Missouri issued the licenses for testing, transporting, and growing facilities.

Medical marijuana dispensary applicants had to pay a non-refundable application fee of $6,000 and an annual license fee of $10,000. Any marijuana business can possess a maximum of 5 dispensary permits, three cultivation licenses, or three manufacturing permits.

Speaking to the media, Bianca Sullivan, the owner of Fresh Green, said that her company won two dispensaries and one would be located in Kansas City while the other in Lee’s Summit.

Sullivan said that she was jumping up and down due to happiness and eventually jumped into the arms of her husband.

Janette Hamilton is the owner of TriCept Wellness, which is based in St. Louis. She said that she was devastated after she got the news that the regulators had rejected the application from her company. She was frustrated because her company’s score was 16th in the 1st Congressional District; however, the regulators selected other applicants with lower ratings and awarded them dispensary permits.

The state did not explain why her company was rejected, said Hamilton.

Applicants for dispensary permits must be residents of Missouri and must present a one-year proof of residency. The business must be owned by people who have been residents of Missouri for at least one year and have no resident privileges in other states. People who have been convicted of drug-related crime cannot own or participate as an employee. The license applicants must also submit a statement showing that all owners have submitted fingerprints and have undergone a criminal background check within the last six months.

Industry actors like HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) may now be happy that arrangements are in high gear to give patients in Missouri a chance to use medical cannabis to manage their health challenges.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Virginia Lawmakers OK Marijuana Decriminalization Bill

On Thursday, Virginia Senators passed a bill decriminalizing marijuana within the state. The legislation removes the threat of imprisonment for simple marijuana possession.

The measure was approved through a voice vote by the Senate Judiciary Criminal Law Subcommittee. The panel debated other measures that were adopted into the passed marijuana legislation, such as the expungement of criminal records and decriminalization proposal.

The subcommittee approved the measure irrespective of the protests from the state chapter of the ACLU. The ACLU argued that the legislation did not protect the people of color from being caught up in the war against drugs and said that they would prefer to wait until the broad legalization of marijuana is achieved.

Although other supporters of the criminal justice reform are in favor of proceeding with certain amendments, they still shared their concerns about the limitations of SB 2. Individuals found guilty of simple possession are liable to a civil penalty, which is punishable by a maximum fine of $50. However, according to the current policy, the same charge attracts a fine of $500 and an additional 30 days in jail.

The legislation would also remove the possession threshold from half an ounce to one once for what is referred to as “intent to distribute.” The definition of hashish would also be removed from state law, and it would be treated as marijuana flower.

Since an expungement provision is in other legislation that has advanced through the Senate, the Senators removed its language from the bill before it was approved. The proposed penalties against juvenile offenders were also reduced.

The subcommittee also agreed to integrate a separate decriminalization bill with a three-tier scheme of offenses, first, second, and third, into SB 2. The measure advancing to the Senate Judiciary Committee stipulates that an offender would be charged a fine of $50 irrespective of the tier.

The Attorney General, Mark Herring, together with the Virginia NORML, testified in favor of the legislation.

Speaking to the media, the Executive Director of Virginia NORML, Jenn Michelle Pedini, said that the panel’s vote is historic and a step in the right direction. Pedini further noted that the lawmakers’ decision to advance the measure is welcome since the state’s marijuana laws have been lagging behind public opinion.

Pedini further said that marijuana criminalization is not solved by decriminalization since decriminalization does nothing to ease the impact of the war against drugs. Therefore, to regulate recreational marijuana and undo the harms of war against drugs, the Commonwealth must swiftly legalize marijuana.

At the beginning of January, during his annual State of the Commonwealth speech, Virginia Gov. Ralph Northam included decriminalization in his policy. He said that leaders need to take a look at the criminal justice system to ensure that people are being treated fairly and that the taxpayers’ money is being used wisely.

Herring is in support of decriminalization, which he believes is a step towards broad marijuana legalization. He is also vying for the governorship in 2021. Last month, Herring organized a summit where officials in legal marijuana educated the lawmakers about regulatory challenges and opportunities. During the summit, Herring said that he would support the governor’s push for comprehensive marijuana reform.

It remains to be seen what companies like SinglePoint Inc. (OTCQB: SING) think of the chances of full cannabis legalization in Virgina now that marijuana has been decriminalized.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.